ATLASTonix Pharmaceuticals Holding (TNXP) earnings date: Nov 9, 2026
Tonix Pharmaceuticals Holding (TNXP) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, before the open. Analysts expect EPS of -$2.51.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TNXP
| Last price | $5.15 (+1.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Tonix Pharmaceuticals Holding stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Tonix Pharmaceuticals Holding reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Tonix Pharmaceuticals Holding. You can switch it off at any time.
Alert me before TNXP reportsFree to start. Creating an account takes under a minute.
Notify me when Tonix Pharmaceuticals Holding reports
Track TNXP free Add Tonix Pharmaceuticals Holding to a free ATLAS watchlist and see its next report date in one place.
TNXP earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$2.51 |
| Last report | Aug 10, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -9.0% |
| Average move around a report | ±6.5% (last 4) |
| Sector | Healthcare · Biotechnology |
Tonix Pharmaceuticals Holding earnings history: last 4 reports
Tonix Pharmaceuticals Holding last reported on Aug 10, 2026: EPS of -$2.47 against an estimate of -$2.62 (+5.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$2.62 | -$2.47 | +5.7% | Beat | +4.7% |
| May 11, 2026 | -$2.54 | -$2.93 | -15.4% | Miss | -5.8% |
| Apr 14, 2026 | $0.44 | $0.48 | +9.1% | Beat | +10.5% |
| Mar 12, 2026 | -$2.94 | -$3.98 | -35.4% | Miss | -5.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TNXP
See the fair value, the probability range and the earnings history of Tonix Pharmaceuticals Holding on its ATLAS page.
Tonix Pharmaceuticals Holding (TNXP) stock analysisPlans from €3.99 a month.
Tonix Pharmaceuticals Holding earnings: frequently asked questions
When does Tonix Pharmaceuticals Holding (TNXP) report earnings?
Tonix Pharmaceuticals Holding is scheduled to report on Monday, November 9, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TNXP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$2.51 per share (USD). Estimates can change before the report.
How often does TNXP beat earnings estimates?
Of its last 4 reports with a recorded result, Tonix Pharmaceuticals Holding beat the EPS estimate 2 times; the average surprise was -9.0%. Past results do not predict the next one.
How much does TNXP move around earnings?
Over its last 4 reports the stock moved an average of 6.5% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Tonix Pharmaceuticals Holding beat earnings estimates last quarter?
Tonix Pharmaceuticals Holding last reported on Aug 10, 2026: EPS of -$2.47 against an estimate of -$2.62 (+5.7% surprise), a beat.
How much does TNXP usually move in a day?
On a normal trading day the ATLAS model puts TNXP’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer